drugset / Trial / NCT00860015
Alimta Plus Gemcitabine for Advanced Sarcoma
NaSingle-groupOpen-labelTreatment
Summary
In patients with unresectable soft tissue sarcoma, what is the response rate if treated with Alimta and gemcitabine?
Timeline
- Start
- 2005-08
- Primary completion
- 2009-08
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | Intravenous |
| Subject | Pemetrexed | Small molecule | 500 mg/m2 | Intravenous |